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consecutive patients, the 
down protocol was determ in random order: 
obtained witb the transvenous lead alone were included 
study. These patients were 61 1: 14 years old (mean I S 
had a mean ejection inaction of 28 + 12%. 
The ability to implant an automatic defibrillator depends on 
achieving adequate defibrillation thresholds. With the use of 
epicardial leads for defibrillation, multiple factors, including 
the shock waveform (1,2), electrode polarity (3), sequential 
versus single shocking pulses (4,5) and phasic duration (6) 
have been demonstrated to influence the defibrillation thresh- 
old. However, the effect of variables uch as electrode polarity 
on defibrillation thresholds has not been determined for 
automatic defibrillators using nonthoracotomy lead systems. 
The purpose of this study was to determine in a randomized, 
prospective manner the effect of electrode polarity of a trans- 
venous lead system on the defibrillation threshold. 
Patient characteristics (Table 1). The mean age I! SD of 
the 20 patients included in the study was 61 + 14 years. Fifteen 
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patients had coronary artery disease, four had idiopathic 
cardiomyopathy and one had no structural heart disease. The 
mean left ventricular ejection fraction was 28 + 12%. Cardiac 
arrest was the presenting symptom in 13 patients, and 7 
patients presented with syncope or sustained ventricular tachy- 
cardia. All patients underwent baseline lectrophysiologic test- 
ing, and electropharmacologic testing with a mean of 1 2 1 
antiarrhythmic drugs was unsuccessful in all before device 
implantation. 
Lead specifications and placement. The CPI Endotak C 
lead (Cardiac Pacemakers, Inc.) was used in this study. It is a 
tined, passive fixation lead, 100 cm in length, and varies along 
its length from 9.5F to 12F in diameter. The lead has a distal 
electrode of 295 mm* and a proximal electrode of 617 mm’, 
which are separated by a distance of 11.5 cm. The tip of the 
lead was positioned with the aid of fluoroscopy in the right 
ventricular apex by way of the subclavian vein. This positioned 
the distal shocking coil in the right ventricle and proximal coil 
in the right atrium. 
All patients came to the operating room in a postabsorptive 
state, Antiarrhythmic medications were stopped at least 5 
half-lives before device implantation i  all patients, with the 
exception of four patients in whom amiodarone therapy had 
been ineffective (Table 1). These patients were taken to the 
operating room 1 to 5 days after discontinuation f amioda- 
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T&lo 1. Defibrillation Data 
Defibrillation Threshold 
Pt 
No. 
1 
2 
3 
4 
5 
6 
7 
8 
9 
IO 
II 
I2 
13 
I4 
I5 
lb 
17 
18 
19 
20 
Mean 
SD 
%“(E 
63/M 
79lF 
751F 
59/F 
43/M 
79/M 
55lF 
64/M 
72/M 
53/M 
3wM 
43/M 
7WM 
72lM 
55/M 
UhM 
77iM 
37/M 
54/M 
67/M 
61 
14 
Heart 
Diiase 
CAD 
CAD 
CAD 
IDCM 
IDCM 
CAD 
CAD 
CAD 
CAD 
CAD 
IDCM 
CAD 
CAD 
CAD 
IDCM 
CAD 
CAD 
None 
CAD 
CAD 
LVEF 
(W 
13 
25 
20 
20 
35 
30 
35 
15 
35 
35 
24 
3s 
30 
311 
M 
20 
20 
65 
I5 
40 
28 
12 
Antiarrhythmic Drug 
During Study 
NOM 
None 
None 
None 
None 
Amio’ 
None 
NOW 
None 
None 
None 
None 
None 
None 
None 
Amio* 
Amio” 
None 
None 
Amio’ 
(J) 
Cathodal Anodal 
20 10 
IS 3 
1.5 10 
10 5 
20 20 
25 IO 
I5 IO 
20 211 
20 15 
25 20 
20 1s 
10 IO 
I 3 
5 IO 
Y 15 
25 8 
2 15 
M 10 
20 10 
25 IO 
I69 11.5 
7.7 S.Oi 
*Discontinued 1 to 5 days before device implamation. tp = 0.94 (anodal vs. cathodal defibrillation threshold). 
Amio = amiodarone; CAD = coronary artery disease; F = female: IDCM = idiopathic dilated cardiomyopathy; LVEF = 
left ventricular ejection fraction; M = male; PI = patient. 
rone. General anesthesia was induced with fentanyl or its 
derivatives and the patients were paralyzed with vecuronium 
bromide, Maintenance anesthesia was achieved with inhalation 
agents: nitrous oxide, halothane, isogurane or entlurane, in 
combination with intravenous fentanyl. 
aotfea aldefibrillation threshold. AU patients pro- 
nt to participate for all procedures under 
by the Human Research Committee of 
tehigan. The defibrillation threshold was 
cd with both of two electrode configurations in ran- 
er (Fig. 1). The deftbrillation threshold was deter- 
mined initially with the distal electrode as the cathode or as the 
and was then determined a second time with the 
reversed. 
ntricular fibrillation was induced using 1 to 3 s of 
alternating current. A truncated monophasic shock with a 
pulse wid? adjusted automatically according to the impedance 
of the %\nocktng system to allow delivery of all the stored energy 
was delivered by an extenai defibrillator (ECD, CPI, Inc.) 10 s 
after the initiation of alternating current. This device measures 
the 
51 
impedance of each recorded shock and has an accuracy of 
of the measured resistance. The defibrillation threshold 
was defined as the lowest first shock energy needed to convert 
ventricular fibrillation to sinus rhythm, 
A step-down protocol was utilized to determine the defi- 
brillation threshold. The delivered energy was given in the 
following order until ventricular fibrillation failed to convert o 
sinus rhythm: 20, 15, 1 , 8, 5, 3, 2, 1 and finally 0.5 J. The 
defibrillation threshold was defined as the lowest energy 
needed to convert ventricular fibrillation to sinus rhythm, 
except when 20 J failed to convert ventricular fibrillation to 
sinus rhythm. In this instance, the defibrillation threshold was 
arbitrarily defined as 25 J. At least 5 min was allowed to elapse 
between each induction of ventricular fibrillation. 
II patients whose defibrillation threshold was >20 J with 
each polarity, a subaxillary subcutaneous patch was implanted 
Fipn 1. The defibrillation threshold was determined in all patients in 
two configurations. Each patient was randomized to have the defibril- 
lation threshold determined initially with either the distal shocking coil 
as the cathode, or negative electrode (left), or with the distal shocking 
coil as the anode, or positive electrode (right). 
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were compared using a Student paired f test. probability values 
CO.05 were considered statistically sig~i~cant. 
The results in individual patients are presented in Table 1. 
ith the distal coil as the anode, the mean defibrillation 
tbres~io~d was 115 t- 5 
distal coil as the cat 
tl~~cs~~old with the distal shocking coil of the transvenous lead 
de WN a mt’all of 0 it 7 J less than that with the 
polarity in 14 p;&icnts, the same as that with the 
olarity in 3 and a mean of 7 + 0 J 
with the rcvcrscd polarity in 3. The mean imp 
5 12 with anodal shocks and 50 + 6 dl with catbodal shocks. 
In five patients the defibrillation threshold was ~25 J with 
the distal electrode as the cathode but 520 J with the distal 
&ctrode as the anode. Thus, in these five patients, the 
addition of a subcutaneous patch to the electrode system was 
avoided by tbe use of anodal shocks. Conversely, none of the 
three patients whose defibrillation threshold was greater with 
the distal coil as the anode would have required a subcutane- 
ous patch if the reversed polarity had not been tested. 
There was no difference in the use of amiodarone, mean 
age, mean left ventricular ejection fraction or type of heart 
disease among patients whose defibrillation threshold was 
lower or higher with the distal coil as the anode or the same 
with both shock polarities. 
There were no distinguishing clinical characteristics among 
the nine patients in whob,. qn adequate defibrillation threshold 
could not be obtained with the transvenous lead alone. How- 
ever, adequate defibrillation thresholds were obtained in these 
nine patients with the addition of a subcutaneous patch 
electrode. 
Main findings. In the conventional polarity configuration 
for automatic defibrillators used in conjunction with a trans- 
venous lead system, the distal electrode is used as the cathode. 
However, the results of this study demonstrate hat the defi- 
brillation threshold is approximately 30% lower with anodal 
shocks than with use of the conventional polarity. In this study, 
the use of the distal electrode as the anode, a configuration 
opposite to that recommended by the manufacturer of the 
lead, obviated the use of a subcutaneous patch in 25% of 
patients. These data suggest that the use of the distal electrode 
as the anode should be the first polarity configuration tested 
when determining the defibrillation threshold using a trans- 
venous lead system. 
riced effect of polarity on 
picardial lead system in 
tion in the defibrillation 
tbreshoId was noted with the left ventricular patch as the 
anode as opposed to the cathode. Consistent with our findings, 
this configuration did not affect he defibrillation tbres~~o~d in 
a few patients and in a few others the defibrillation threshold 
lower with the left ventricular patch as the cathode (3). 
ever, regardless of configuration, the mean defibrillation 
threshold in that study was 40 J. In the present study, using 
a t~a~~svenQus lead ystem, the mean defibrillation thres 
were sig~~fica~tly higher than those obtained with epic 
ecause the defibrillation threshold must be 520 J to 
use a transvcaous lead sys?em, a decrease of32%, from a mean 
of 16.0 J lo 1 I.5 9, may significantly affect ability to implant a 
defibrillator with a nonthoracotomy lead system in some 
s. The mechanism by w 
shocks lower the defibrillation threshold from that obtained 
with cathodal shocks cannot be elucidated from our data. 
However, two possible mechanisms are hypothesized. The first 
hypothesis, and perhaps the most plausible, relates to the 
“anodal dip” observed during cardiac pacing. Anodal pacing is 
associated with lower stimulation thresholds during the rela- 
tive refractory period (7). As most cardiac myocytes are in their 
relative refractory period during ventricular fibrillation, anodal 
shocks might be expected to result in more complete depolar- 
ization than that achieved with cathodal shocks (3). A second 
possibility includes a change in the current density with 
reversal of polarity, which could possibly lower defibrillation 
threshold. 
~i~~t~tions of the study. The major limitation of this 
study, as with other defibrillation threshold studies in humans, 
is that a defibrillation threshold curve was not constructed. The 
defibrillation threshold is not an absolute number but repre- 
sents a statistical phenomenon (S), with its value a function of 
the technique used to determine it. However, construction ofa 
defibrillation curve requires multiple defibrillations atvarious 
energy levels and IJ not clinically feasible. 
A second limitation is that a consistent regimen for induc- 
tion of anesthesia was not utilized, although the level of 
maintenance anesthesia, during which defibrillation thresholds 
were determined, was the same for all patients. The effect of 
general anesthesia on defibrillation thresholds in humans has 
not been determined; however, animal studies (9-I I) suggest 
that defibrillation thresholds are unaffected by a variety of 
anesthetic agents. 
Clinical lmpIications. The results of this tudy indicate that 
use of the distal electrode as the anode provides the most 
effective polarity configuration of an endocardial lead system. 
Therefore, when defibrillation thresholds are being tested with 
a transvenous lead, an anodal shock polarity should be the first 
polarity tested. In the current study, this configuration obviated 
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the need for a subcutaneous patch in 25% of patients. Addi- 
tionally, it is possible that if only cathodal shocks had been 
tested, some of these patients might have had inadequate 
defibrillation thresholds even with a subcutaneous patch and 
thus, might have required a thoracotomy for placement of an 
epicardial lead system. Furthermore, even when cathodal 
shocks are effective, utilization of anodal shocks may provide 
larger defibrillation safety margins when implanting a detibril- 
later with a transvenous lead system. In turn, this may allow for 
implantable detibrillators that have lower maximal outputs 
than those of current devices, thereby facilitating the develop- 
ment of smaller devices. 
Bardy GH. lvcy TD, Allen MD, Johnson G, Mohru BR, Grcenc HL. A 
prospccfive randomized cvaluution rrf hiphasic versus munaphasic waveform 
p&es on defihrilknion CH~UCY in humans. 3 Am Cell Cardiel 19N9;I4:728- 
33. 
Winkle RA, Moiul RH, Ruder MA. CI al. fmprovcd low cncrgy tlstibrillation 
JACC Vol. 24, No. 4 
October lYY4:1MY-72 
eficacy in man with the use of a hiphasic truncated expenemial wavcfbrm. 
Am Heart J 1989;117:122-7. 
3. Bardy GH, lvey TD, Allen MD, Johnson 6, Greene HL. Evaluation of 
electrode polarity on defibrillation efficacy. Am J Cardiol 1989$13:433-7. 
4. Bardy GH, Stewart RB, lvey TD. Graham EL, Adhar GC. Grecnc HL. 
Intraoperative comparison of sequential pulse and sin& pulse defibrillation 
in candidates for automatic defihrillators. Am J Cardiul I987:blk618-24. 
5. Jones DL, Klein GJ, Guiraudon GM, Sharma AD. Seyueniial pulse defi- 
brillation in humans: orlhogonal sequential pulse defibrillation with epicar- 
dial electrodes. J Am Coil Cardiol 19X8;11:590-ti. 
6. Tang ASL. Yabe S. Wharton JM. Doler M, Smith WM, ldeker RE. 
Ventricular deiihrillation using hinhasic waveforms: the imuortance of 
7. 
8. 
9. 
IO. 
II. 
phasic duration. J Am Cull Ca~iol’l~~~~l3:207-l~, ’ 
Cranelield PF. floffman BF. Sichens AA. Anodal cxcitaticm of cardiac 
muscle. Am J Physiol l9~~1’~~:~~3-‘~~. 
Singer I, Lang 1). Defihrillatiun threshold: clinical utility and therapeutic 
implicalions. PACE Pacing Clin Eleotrophysiol 1992;lS:Y32-49. 
Gill R. Swecncy R, Reid I’. The defihrilknion threshold: ;I comparison of 
anesthetics and measurement methods. PACE Pacing Clin Elcctrophysiol 
l993:lfx7O&IJ. 
Bahlm CF. E&I of p~n~oharbi~ul m rsthcsia on vcmricular dclihrilla~itrn i
dogs. Am Heart J 19%;95:33 I-7. 
Wang M. D&n I’. DL and D sotalel decreasr dclihrillation energy 
reyuircmsnts. PACE P;u%g Clin Electrophysiol I989;l? IS?2-9. 
